iNtRON Biotechnology Inc (048530) — Working Capital to Net Assets Ratio
iNtRON Biotechnology Inc (048530) has a Working Capital to Net Assets ratio of 57.7% as of September 2025. Working capital of ₩42.70 Billion (current assets of ₩47.10 Billion minus current liabilities of ₩4.40 Billion) is measured against net assets of ₩73.98 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See iNtRON Biotechnology Inc (048530) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
iNtRON Biotechnology Inc Working Capital to Net Assets (2012–2024)
This chart shows how iNtRON Biotechnology Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 57.7%, reflecting working capital of ₩42.70 Billion against net assets of ₩73.98 Billion KRW. Check iNtRON Biotechnology Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for iNtRON Biotechnology Inc (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for iNtRON Biotechnology Inc from 2012 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see iNtRON Biotechnology Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.7% | ₩50.89 Billion | ₩83.77 Billion | ₩52.23 Billion | ₩1.34 Billion | ▼ -1.5 pp |
| 2023 | 62.2% | ₩60.19 Billion | ₩96.73 Billion | ₩60.98 Billion | ₩785.97 Million | ▼ -14.7 pp |
| 2022 | 77.0% | ₩81.71 Billion | ₩106.18 Billion | ₩113.93 Billion | ₩32.22 Billion | ▼ -14.1 pp |
| 2021 | 91.0% | ₩92.26 Billion | ₩101.35 Billion | ₩125.51 Billion | ₩33.25 Billion | ▲ +10.7 pp |
| 2020 | 80.4% | ₩68.62 Billion | ₩85.38 Billion | ₩81.33 Billion | ₩12.70 Billion | ▼ -28.3 pp |
| 2019 | 108.7% | ₩70.61 Billion | ₩64.96 Billion | ₩75.29 Billion | ₩4.68 Billion | ▲ +42.2 pp |
| 2018 | 66.5% | ₩25.99 Billion | ₩39.09 Billion | ₩40.16 Billion | ₩14.17 Billion | ▲ +9.3 pp |
| 2017 | 57.1% | ₩17.28 Billion | ₩30.24 Billion | ₩31.10 Billion | ₩13.82 Billion | ▲ +2.9 pp |
| 2016 | 54.2% | ₩26.65 Billion | ₩49.15 Billion | ₩34.76 Billion | ₩8.11 Billion | ▲ +7.8 pp |
| 2015 | 46.4% | ₩15.99 Billion | ₩34.44 Billion | ₩19.26 Billion | ₩3.27 Billion | ▲ +12.2 pp |
| 2012 | 34.2% | ₩4.08 Billion | ₩11.93 Billion | ₩8.26 Billion | ₩4.18 Billion | — |